Výsledky vyhledávání - "M. Nabeel Rajeh"

Phase II Study of Oral Rigosertib Combined with Azacitidine (AZA) As First Line Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS)

Autor: David Young, Guillermo Garcia-Manero, Ehab Atallah, Shyamala C. Navada, Afoluso Ronnee Adesanya, Elizabeth A. Griffiths, Rosalie Odchimar-Reissig, Pierre Fenaux, Jamile M. Shammo, Richard C. Woodman, Shaker R. Dakhil, Patrick S. Zbyszewski, M. Nabeel Rajeh, Samer K. Khaled, Lewis R. Silverman

Publikováno v: Blood. 134:566-566

Background: AZA monotherapy has demonstrated improvement in OS in HR MDS, clinically meaningful and durable responses continue to be limited to a subset of patients (Silverman 2006). One obvious strategy is to develop doublet therapy with drugs that

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4b84366f0f5ea6c15b33629afb339899
https://doi.org/10.1182/blood-2019-131676

Zobrazit plný text záznamu

Quality Improvement Project: Workflow, Standardization and Data Validation of Comorbidity Index at a Small to Medium Volume Transplant Center

Autor: M. Nabeel Rajeh, Sagun D. Goyal, Igryl Cordero, Jack M. Lionberger, Zahir Ali, Nisarg P. Patel, Mark Fesler

Publikováno v: Biology of Blood and Marrow Transplantation. 23:S416-S417

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e11a46068d4d32ccbfb05c14a50263f0
https://doi.org/10.1016/j.bbmt.2016.12.504

Zobrazit plný text záznamu

Phase 2 Expansion Study of Oral Rigosertib Combined with Azacitidine (AZA) in Patients (Pts) with Higher-Risk (HR) Myelodysplastic Syndromes (MDS): Efficacy and Safety Results in HMA Treatment Naïve & Relapsed (Rel)/Refractory (Ref) Patients

Autor: Steven M. Fruchtman, Lewis R. Silverman, Shaker R. Dakhil, Ehab Atallah, Yesid Alvarado, Shyamala C. Navada, M. Nabeel Rajeh, Naveen Pemmaraju, Maro Ohanian, Samer K. Khaled, David Young, Guillermo Garcia-Manero, Rosalie Odchimar-Reissig, Michael E. Petrone, Jamile M. Shammo, Patrick S. Zbyszewski, Rosmy B. John, Manoj Maniar, Elizabeth A. Griffiths

Publikováno v: Blood. 132:230-230

Background: AZA is first line therapy for pts with HR-MDS with an overall response rate (ORR) between 35 and 60% in various publications; with CR/PR rates ranging between 23 and 29% in 3 randomized phase II/III studies (Silverman et al., JCO 2002; Fe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::732b53f67fed37777633e64ce1ead39a
https://doi.org/10.1182/blood-2018-99-119259

Zobrazit plný text záznamu

Diagnosis and Management of Acute Closed Angle Glaucoma after Autologous Hematopoietic Stem Cell Transplant

Autor: Dina Dababneh, Florian P. Thomas, Tori Holmes, Jack M. Lionberger, Hayley Klein Chopra, M. Nabeel Rajeh

Publikováno v: Biology of Blood and Marrow Transplantation. 22(3):S125-S126

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2cfd7376c5c74b436a89b7801704358

Zobrazit plný text záznamu

Quality Improvement Project: Pre-Transplant Disease Classification of Multiple Myeloma with Formal Data Validation Process at a Small to Medium Sized Transplant Center

Autor: Carl E. Freter, Michael Pan, Kristin Kalinowski, M. Nabeel Rajeh, Nisarg P. Patel, Sagun D. Goyal, William Thinnes, Jack M. Lionberger

Publikováno v: Biology of Blood and Marrow Transplantation. 23:S415

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::021469d0172ee254040438ea51a526c4
https://doi.org/10.1016/j.bbmt.2016.12.503

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání